Welcome to the July Issue of GHP Magazine.
This month we have a speech by Gabriel Wikström, the Swedish Minister for Health, discussing antimicrobial resistance and the Swedish government’s actions against it.
We also take a look at the Nordic Life Science days, a global event bringing together leaders in the global life science industry.
Focusing on diabetes, we pinpoint a clinical trial which shows the benefits of Biocool, a foot bath product, for treating foot issues often prevalent among diabetes sufferers.
Innovative new treatment for tendinopathy is analysed this month as we examine the potential effects that CollPlant’s new product could have on healthcare.
We turn the spotlight on the NHS, examining a new Healthwatch report which shows that the discharge procedures within the service need drastic remodelling.There is also a report about the drop in organ donation and the effect this is having on an already strained service.
There is also a piece about how a potential British exit from the Euro could affect the life sciences industry and we have an exclusive interview with Dr Rossant of the Ontario Institute for Regenerative Medicine, who outlines the effects that new government funding will have on the research being done at the institute.
We hope you enjoy this issue!